$BCLI bottom Pr $3.87

New Post Public Reply Private Reply Replies (0) Message Board
PoemStone
$BCLI bottom Pr $3.87


Website

NEW YORK and PETACH TIKVAH, Israel , Oct. 7, 2014 /PRNewswire/ -- BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI), a leading developer of adult stem cell technologies for neurodegenerative diseases, announced today that the United States Food and Drug Administration (FDA) has designated NurOwn™ as a Fast Track product for the treatment of amyotrophic lateral sclerosis (ALS, or Lou Gehrig's Disease). NurOwn™ consists of autologous mesenchymal stem cells that have been induced to secrete neurotrophic factors, and is currently being studied in a randomized, double-blind, placebo-controlled phase 2 clinical trial in ALS patients.

"We are pleased that the FDA has granted Fast Track status for NurOwn™ as this will allow us greater and more frequent dialogue with the Agency as we continue the development of this ground-breaking cell therapy for the treatment of ALS," said Tony Fiorino , MD, PhD, Chief Executive Officer of BrainStorm. "We expect Fast Track designation, which recognizes the potential of NurOwn™ as to address an unmet medical need in ALS, to help speed and improve our development program."

The FDA's Fast Track program is designed to facilitate the development and expedite the review of drugs and biologics intended to treat serious conditions and demonstrate the potential to address unmet medical needs. Under the FDA Modernization Act of 1997, the Fast Track program provides for increased meetings with and written communications from the FDA, and allows for the submission of an NDA on a rolling basis. For more information, see http://www.fda.gov/ForPatients/Approvals/Fast/ucm405399.htm .

About BrainStorm Cell Therapeutics Inc.

BrainStorm Cell Therapeutics Inc. is a biotechnology company engaged in the development of first-of-its-kind adult stem cell therapies derived from autologous bone marrow cells for the treatment of neurodegenerative diseases. The Company holds the rights to develop and commercialize its NurOwn™ technology through an exclusive, worldwide licensing agreement with Ramot, the technology transfer company of Tel Aviv University . NurOwn™ has been administered to over 30 patients with ALS in clinical trials conducted in Israel , and is currently being studied in a randomized, double-blind, placebo-controlled clinical trial in the United States.

Shares Outstanding: 15.16M
Float: 11.34M




Headlines

Tuesday, October 7, 2014
FDA Grants Fast Track Designation to NurOwn™ for the Treatment of ALSPR Newswire

Monday, October 6, 2014
BrainStorm Reports Last Patient Visit in Phase 2a ALS StudyPR Newswire

Friday, October 3, 2014
BRAINSTORM CELL THERAPEUTICS INC. FinancialsEDGAR Online Financials

Tuesday, September 30, 2014
BrainStorm Completes Uplisting to the NASDAQ Capital MarketMarketwired

Tuesday, September 16, 2014
BRAINSTORM CELL THERAPEUTICS INC. Files SEC form 8-K, Material Modification to Rights of Security Holders, AmendmentsEDGAR Online
BrainStorm Announces Completion of Reverse Split of Common Stock, a Key Step for Uplisting on the NASDAQAccesswire
Tuesday, September 9, 2014
BrainStorm Provides Update on NASDAQ Uplisting ProcessMarketwired

Thursday, September 4, 2014
BrainStorm to Present at the Rodman and Renshaw 16th Annual Global Investment ConferenceAccesswire

Wednesday, September 3, 2014
BrainStorm Granted European Patent Covering its Stem Cells for the Treatment of CNS DiseasesAccesswire

Monday, August 18, 2014
FDA Clears Mayo Clinic for Manufacture of NurOwn and Participation in BrainStorm’s Phase 2 ALS TrialAccesswire

Wednesday, August 13, 2014
BCLI: Brainstorm Moves Into Phase 2 ALS TrialZacks Small Cap Research

Wednesday, July 30, 2014
Coverage initiated on Brainstorm Cell Therapeutics by Maxim GroupBriefing.com

Monday, July 28, 2014
BrainStorm Receives Notice of Allowance on US PatentAccesswire

Tuesday, July 15, 2014
BrainStorm Announces that University of Massachusetts Memorial Medical Center to Begin Enrolling Patients in Phase 2 ALS Clinical TrialAccesswire

Friday, July 11, 2014
BrainStorm Announces Publication of Preclinical Multidose Study of NurOwnMarketwired

Friday, June 27, 2014
BrainStorm Cell, Octane construct bioreactor prototype for NurOwntheflyonthewall.com
BrainStorm and Octane Successfully Construct a Bioreactor Prototype for Industrial-Scale Manufacturing or NurOwn Stem CellsMarketwired

Tuesday, June 24, 2014
Brainstorm Cell Therapeutics, Inc.: A Small Biotech With Big Plans And Huge Potentialat Seeking Alpha

Friday, June 13, 2014
BrainStorm Cell Therapeutics Raises $10.5 Million in Private Placement FinancingMarketwired

Thursday, June 12, 2014
BrainStorm Tackles Neurodegenerative Diseases With Novel Cell Therapyat Seeking Alpha



BrainStorm Cell Therapeutics Inc. (BCLI) Stock Research Links

BCLI Board Company Profile Buy Rating Time & Sales News Filings Financials
Featured stocks: Coffee Shoppe
For conservative debate: "Keeping it Real"
Game Changing stock $SHMP

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Tarte's Record-Breaking Collab: 60 Seconds to Sellout

Updated Category News Views 71

When Makeup Meets Pajamas: The Perfect Storm Picture this: a makeup brand and a lifestyle label dreaming up a collaboration that sends consumers into a full-blown frenzy. In a whirlwind that lasted just 60 seconds, tarte's latest partnership with Roller Rabbit blazed through stock, cementing its place as a record-breaking phenomenon. Maureen Kelly, tarte’s intrepid CEO,...

Continue Reading
Greasezilla to Process 15M Gallons of FOG Yearly

Updated Category News Views 37

Greasezilla Steps Up for FOG Processing If there’s one thing that makes dealing with wastewater a greasy business, it’s FOG - fats, oils, and grease. It’s the stuff nightmares are made of for any utility trying to keep their pipes clear and their operations running smooth. Now, Greasezilla is stepping into the spotlight at one of the country's largest wastewater...

Continue Reading
AbsenceSoft's AI Leave Planner Tackles HR Headaches

Updated Category News Views 39

Pioneering Technology in Leave Management AbsenceSoft is rolling out a tool that's about to shake up the HR world in a big way. MyAbsence, powered by AbsenceSoftAI, seems ready to cut down on the common confusions that send HR folks spinning around like they're in a two-step dance competition, juggling leave requests and compliance checks. It's all about getting the...

Continue Reading
Systemair Wins First Natural Refrigerant Heat Pump Deal

Updated Category News Views 77

Systemair Breaks New Ground Hold onto your hats, because Systemair just sealed a deal that's going to make waves. Their recent accomplishment isn't just some humdrum business tedium—it's an intriguing step forward in the HVAC world. Systemair snagged their very first order for air handling units featuring an integrated heat pump and natural refrigerant. You've got to...

Continue Reading
AI Shift: From Tech Marvels to Practical Uses

Updated Category News Views 80

A New Chapter in the AI Narrative Take a seat, folks, because we're watching AI swing from showy tech to something as plain as plumbing infrastructure. Imagine models that once cost bundles per token now going for peanuts. We're talking a nosedive from $37.50 to a mere 18 cents. It’s a seismic shift, steering the conversation from 'Are they the best models?' to 'How...

Continue Reading
Lemon Grove Bans Bird Sales to Combat Cruelty

Updated Category News Views 52

A Bird's Eye View on Lemon Grove's Bold Stand The folks in Lemon Grove, California, just sent out a loud and clear message: put an end to the inhumane sale of birds in pet stores. With 65% of voters backing Measure E, they've decided that birds fly best when they aren't part of a retail circus. Under this new rule, stores can only put birds up for adoption if they're...

Continue Reading
Kaolin Market Surges to $8.89B by 2031: Key Trends

Updated Category News Views 91

Riding the Kaolin Wave: Industrial Market Expansion You can't miss the sound of kaolin clinking in as it rides the tide of industrial demand. Reports from MarketsandMarkets™ have kaolin's party rocking all the way to a hefty $8.89 billion by 2031, up from $6.19 billion in 2026. With a sensible 7.5% compound annual growth rate (CAGR), this clay’s is aiming for the...

Continue Reading
Hormel Foods Sets Stage for Q4 Earnings Call in December

Updated Category News Views 124

Hormel Foods Prepares for Earnings Spotlight In a world where market instability feels like the only constant, Hormel Foods Corporation (NYSE:HRL) is setting up one of those must-watch moments. You've got DECEMBER 3rd circled on your cal, right? If not, you're about to miss a curtain raiser that could send ripples across portfolios. Setting the Stage: December's Big...

Continue Reading
LONGi Achieves 10th BNEF Tier 1 Listing Amidst Stricter Rules

Updated Category News Views 111

LONGi Surpasses New BNEF Barriers with Ease Alright, let's dig into the meat of the matter today. LONGi has snagged its 10th straight spot in BloombergNEF's (BNEF) Tier 1 list of global energy storage manufacturers. And mind you, that's no small potatoes, especially with stricter financing demands rearing their hefty heads this quarter. Non-Recourse Financing: A Tougher...

Continue Reading
UN Forum Unleashes LatAm CEO Coalition for Action

Updated Category News Views 89

Latin America Takes Center Stage When the UN turns its spotlight on a region, you know there's something afoot. Right in Montevideo, Uruguay, the United Nations Global Compact gathered a hefty crowd of over 300 leaders from diverse backgrounds—think business, finance, government, and academia. What they were brewing wasn’t just talk; it was about driving real change...

Continue Reading

Top 5 Most Recently Viewed Articles

Interoil Exploration's Production Report for Early 2025

Updated Category News Views 300

Interoil Exploration's Production Report for Early 2025 Oslo, April 29 – Interoil Exploration and Production ASA has recently unveiled its production report for early 2025, providing stakeholders with critical insights into operational performance across key regions. This report highlights the company’s achievements and challenges faced in producing oil and gas from...

Continue Reading
Cary Claiborne Shares Insights on Adial Pharmaceuticals' Progress

Updated Category News Views 143

Cary Claiborne Shares Insights on Adial Pharmaceuticals' Progress GLEN ALLEN, Va. — Adial Pharmaceuticals, Inc. (NASDAQ: ADIL), a biopharmaceutical company dedicated to addressing addiction and related disorders, recently had its CEO, Cary Claiborne, spotlighted as a featured guest on an influential radio and TV program. The Big Biz Show: A Platform for Insightful...

Continue Reading
KickHouse Partners with Sam Alvey for Glove Line Launch

Updated Category News Views 105

KickHouse Pounces with New Fighter Partnership Looks like KickHouse isn't playing games, folks. They've teamed up with fighter Sam Alvey to launch a new boxing glove line. You got your Warbird, your Desert Ghost, and your Night Ops gloves—names straight out of a war zone. These 16-ounce hammers are out now, and they kickstart a broader gear lineup custom-built for Alvey...

Continue Reading
Methode Electronics Faces Class Action: Key Dates and Details

Updated Category News Views 178

Details on the Class Action Lawsuit Against Methode Electronics Investors need to take note of important deadlines linked to the class action lawsuit against Methode Electronics, Inc. (MEI). This legal action has been initiated for shareholders who bought MEI stock at a time when the company faced significant financial challenges. It's crucial for those affected to stay...

Continue Reading
Alpha Structural Achieves Remarkable Growth Amid Challenges

Updated Category News Views 229

Alpha Structural's Achievement in Business Growth With a remarkable three-year revenue growth of 77 percent, Alpha Structural, Inc. has claimed the prestigious spot of No. 4335 on the Inc. 5000 list of America’s fastest-growing private companies. This accolade marks the firm’s fourth appearance on this esteemed list, distinctively showcasing its sustained growth even...

Continue Reading